■ Healthcare
Continued From Page 52 ProCure Proton Therapy Center By Brian Chon , M . D ., Medical Director
When someone is diagnosed with cancer , they aren ’ t the only ones affected . Ron and Pat know this all too well and nothing prepared them for the shock of a prostate cancer diagnosis . When exploring treatment options , Ron ’ s doctor recommended proton therapy as the ideal solution . In fact , Ron ’ s doctor was so confident in the effectiveness of proton therapy that he said he would recommend it to his own father . Standard X-ray radiation treatments for prostate cancer can run the risk of damaging particularly sensitive areas of the body and finding a non-invasive solution that would spare surrounding healthy tissue and organs was a huge relief for this couple . At ProCure , both Ron and Pat found a support network unlike no other . Everyone from the front desk concierges to the oncologist team was incredibly compassionate and knowledgeable . It became obvious that ProCure offered the best of both worlds : a stateof-the-art facility with a first-class treatment team . For countless couples , cancer means a long , hard road of stress and sacrifice . Ron and Pat found the exact opposite . To their surprise , Ron experienced generally no side effects before ,
during and after each treatment session . Without the discomfort and exhaustion typically associated with cancer treatments , both Ron and Pat were able to look forward to what tomorrow would bring .
RWJBarnabas Health , Rutgers Cancer Institute of New Jersey By James K . Aikins , Jr ., M . D ., FACOG , FACS , Chief , Gynecologic Oncology ; Associate Professor of Obstetrics , Gynecology and Reproductive Sciences , Rutgers Robert Wood Johnson Medical School
Although ovarian cancer is among the most difficult cancers to treat when not caught in its earliest stages , treatment advances such as clinical trials are improving the quality of life of many patients . At Rutgers Cancer Institute of New Jersey and RWJBarnabas Health , investigators are exploring clinical trials to see whether new treatments for ovarian cancer are safe and more effective than those currently available . This includes trials that examine immune checkpoint inhibitors in addition to those that combine existing FDA-approved treatments . Physician-scientists are also studying how to reduce the risk of ovarian cancer in women who are BRCA1 gene carriers by comparing bilateral salpingectomy , which is the surgical removal of fallopian tubes with delayed bilateral salpingo-oophorectomy , which is the surgical removal of both the fallopian tubes and ovaries . Along with clinical trials , our programs offer other advanced treatment options including minimally invasive surgical techniques , cytoreductive surgery and hyperthermic intraperitoneal chemotherapy ( HIPEC ), precision medicine and immunotherapy .
Saint Peter ’ s University Hospital By Gopal Desai , M . D ., Chairman , Department of Radiation Oncology
My patient was diagnosed with prostate cancer at age 65 . He chose to get treatment at Saint Peter ’ s University Hospital because we have the CyberKnife ® Robotic Stereotactic Radiosurgery System , an advanced technology that delivers a specialized form of radiation therapy called stereotactic radiosurgery , or stereotactic body radiation . During CyberKnife procedures , patients receive high doses of radiation directly to their tumor with sub-millimeter precision , minimizing exposure to surrounding healthy tissue . Each session of this non-surgical , non-invasive treatment is 30 minutes to 90 minutes long . CyberKnife technology also treats tumors in the
Continued On Page 56
A radiologist speaks to a patient who is about to receive an MRI for prostate cancer .
Photo : Getty Images / iStockphoto / skynesher
54 COMMERCE www . commercemagnj . com